Medicine for treating secondary lung tuberculosis and preparation method thereof

A tuberculosis, secondary technology, applied in the direction of pharmaceutical formulas, medical preparations containing active ingredients, antibacterial drugs, etc., can solve the problem that the continuous medication time is not less than nine to 12 months before the drug is discontinued, and the drug cannot be obtained. Effectively control problems such as patients' inability to insist on taking it, and achieve the effect of improving the body's immune function, improving tuberculosis symptoms, and reliable curative effect

Active Publication Date: 2009-04-29
TONGHUA JITONG PHARMA
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Pulmonary tuberculosis is mainly treated with chemotherapy drugs such as rifampicin, isoniazid, pyrazinamide, ethambutol, etc., which have definite curative effects and are legally prescribed drugs. During this period, due to the inevitable toxic and side effects of such chemotherapy drugs, some patients cannot persist in taking the full course of treatment or frequently change the treatment plan because a certain drug in the chemotherapy plan is not suitable for the individual to take, resulting in no effective control , the disease progressed, and some cases were treated with surgical lung resection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating secondary lung tuberculosis and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] The medicine for the treatment of secondary pulmonary tuberculosis is made from the following raw materials by weight: 150 parts of astragalus, 75 parts of lily, 75 parts of Ophiopogon japonicus, 60 parts of Fritillaria chinensis, 112.5 parts of Houttuynia cordata, 112.5 parts of Huhuanglian, 90 parts of cat's claw , 112.5 parts of Baibu, 75 parts of Campanulaceae, 37.5 parts of Panax notoginseng, and 75 parts of Baiji.

Embodiment 2

[0020] The medicine for the treatment of secondary pulmonary tuberculosis is made from the following raw materials by weight: 120 parts of astragalus, 90 parts of lily, 90 parts of Ophiopogon japonicus, 75 parts of Fritillaria chinensis, 135 parts of Houttuynia cordata, 135 parts of Huhuanglian, 110 parts of cat's claw , 90 parts of Baibu, 60 parts of Bellflower, 30 parts of Panax notoginseng, and 60 parts of Baiji.

Embodiment 3

[0022] The medicine for the treatment of secondary pulmonary tuberculosis is made from the following raw materials by weight: 180 parts of astragalus, 60 parts of lily, 60 parts of Radix Ophiopogon japonicus, 45 parts of Fritillaria, 90 parts of Houttuynia cordata, 90 parts of Huhuanglian, 75 parts of cat's claw , 135 parts of Baibu, 90 parts of Bellflower, 45 parts of Panax notoginseng, and 90 parts of Baiji.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a Chinese materia medica preparation, in particular to a traditional Chinese composition of Beiqi lung supplement tablet used for phithis, which is particularly applicable to Qiyin damage symptoms of secondary tuberculosis of lung. The traditional Chinese composition is prepared by the materials of the following weight portions: 120 to 180 portions of milk veteh, 60 to 90 portions of lily roots, 60 to 90 portions of ophiopogon roots, 45 to 75 portions of fritillary bulb, 90 to 135 portions of ordate houttuynia, 90 to 135 portions of Radix picrorrhizae, 75 to 110 portions of ternate buttercup roots, 90 to 135 portions of stemona, 60 to 90 portions of balloon flower, 30 to 45 portions of Panaxnotoginseng, and 60 to 90 portions of Bletilla striata. The traditional Chinese composition has the effects of supplementing qi and nourishing yin, moistening the lung and relieving the cough, and growing muscles and stanching bleeding, can rapidly relieve tuberculosis symptoms, has relatively ideal effects in the major aspects of preventing cough, eliminating phlegm, stanching bleeding, resisting inflammation, regulating immune and the like, and can reduce side-effects of chemo-treatment, facilitate sputum negative conversion, focus absorption and pore closure. The side-effects are small and the medical healing effects are reliable; moreover, the traditional Chinese composition is worthy of being popularized and applied.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, which is Beiqi Yifei Tablet, which is a traditional Chinese medicine composition used for pulmonary tuberculosis, and is especially suitable for secondary pulmonary tuberculosis with qi and yin depletion syndrome. Background technique [0002] Clinically, according to the classification of Western medicine, "secondary pulmonary tuberculosis" is more common. Secondary pulmonary tuberculosis is also called adult-onset pulmonary tuberculosis. It refers to children who have been infected with tuberculosis. There are two possibilities for the onset of active pulmonary tuberculosis: one is that the old primary tuberculosis bacilli become active again, causing the focus to flare up, which is called endogenous recurrence; the other is that tuberculosis is reinfected from the outside after the primary infection has been cured. Bacillus and the disease, said exogenous reinfection. Secondary pu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/904A61P31/06
Inventor 杨静
Owner TONGHUA JITONG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products